Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1172)
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
1,431
Price
$74.45
Total Value
$106.53K
Shares Held After
11,014
% of Holdings
11.5%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
8,680
Price
$73.35
Total Value
$636.70K
Shares Held After
12,445
% of Holdings
41.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
124
Price
$99.97
Total Value
$12.40K
Shares Held After
85,533
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
7,434
Price
$99.29
Total Value
$738.12K
Shares Held After
85,657
% of Holdings
8.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,872
Price
$98.42
Total Value
$381.08K
Shares Held After
93,091
% of Holdings
4.0%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
2,243
Price
$32.79
Total Value
$73.55K
Shares Held After
36,621
% of Holdings
5.8%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$203.33
Total Value
$1.22M
Shares Held After
378,682
% of Holdings
1.6%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
40,000
Price
$50.10
Total Value
$2.00M
Shares Held After
2,878,326
% of Holdings
1.4%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
143
Price
$31.00
Total Value
$4.43K
Shares Held After
66,083
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
14,023
Price
$30.16
Total Value
$422.99K
Shares Held After
66,226
% of Holdings
17.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
800
Price
$234.02
Total Value
$187.21K
Shares Held After
41,382
% of Holdings
1.9%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,420
Price
$232.92
Total Value
$330.75K
Shares Held After
42,182
% of Holdings
3.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
780
Price
$232.04
Total Value
$180.99K
Shares Held After
43,602
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
370
Price
$230.87
Total Value
$85.42K
Shares Held After
44,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
98
Price
$229.71
Total Value
$22.51K
Shares Held After
44,752
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
932
Price
$228.75
Total Value
$213.20K
Shares Held After
44,850
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
600
Price
$227.45
Total Value
$136.47K
Shares Held After
45,782
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
289
Price
$83.16
Total Value
$24.03K
Shares Held After
173,371
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$82.60
Total Value
$74.34K
Shares Held After
173,660
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
811
Price
$81.02
Total Value
$65.71K
Shares Held After
174,560
% of Holdings
0.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
58,394
Price
$0.73
Total Value
$42.63K
Shares Held After
1,727,293
% of Holdings
3.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,683
Price
$24.90
Total Value
$116.61K
Shares Held After
110,342
% of Holdings
4.1%
Moderna, Inc. (MRNA)
Hussain Abbas — Director
Shares
5,682
Price
$46.63
Total Value
$264.95K
Shares Held After
12,066
% of Holdings
32.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,362
Price
$571.95
Total Value
$779.00K
Shares Held After
40,513
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,197
Price
$571.22
Total Value
$1.83M
Shares Held After
41,875
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,621
Price
$570.28
Total Value
$2.06M
Shares Held After
45,072
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
843
Price
$569.18
Total Value
$479.82K
Shares Held After
48,693
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
197
Price
$568.37
Total Value
$111.97K
Shares Held After
49,536
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$567.17
Total Value
$45.37K
Shares Held After
49,733
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$565.78
Total Value
$113.16K
Shares Held After
49,813
% of Holdings
0.4%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$714.13
Total Value
$1.43K
Shares Held After
17,503
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$712.09
Total Value
$712.09
Shares Held After
17,505
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$711.49
Total Value
$3.56K
Shares Held After
17,506
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$710.87
Total Value
$1.42K
Shares Held After
17,511
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
6
Price
$709.45
Total Value
$4.26K
Shares Held After
17,513
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
4
Price
$707.40
Total Value
$2.83K
Shares Held After
17,519
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$706.74
Total Value
$4.95K
Shares Held After
17,523
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
14
Price
$705.56
Total Value
$9.88K
Shares Held After
17,530
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
15
Price
$704.28
Total Value
$10.56K
Shares Held After
17,544
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
24
Price
$703.46
Total Value
$16.88K
Shares Held After
17,559
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
15
Price
$702.46
Total Value
$10.54K
Shares Held After
17,583
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$701.76
Total Value
$3.51K
Shares Held After
17,598
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
23
Price
$160.00
Total Value
$3.68K
Shares Held After
3,666
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
38
Price
$159.08
Total Value
$6.04K
Shares Held After
3,689
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
65
Price
$158.35
Total Value
$10.29K
Shares Held After
3,727
% of Holdings
1.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
106
Price
$157.45
Total Value
$16.69K
Shares Held After
3,792
% of Holdings
2.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
82
Price
$156.24
Total Value
$12.81K
Shares Held After
3,898
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
346
Price
$155.48
Total Value
$53.79K
Shares Held After
3,980
% of Holdings
8.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
288
Price
$154.38
Total Value
$44.46K
Shares Held After
4,326
% of Holdings
6.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
52
Price
$153.89
Total Value
$8.00K
Shares Held After
4,614
% of Holdings
1.1%
Showing 851–900 of 1172 transactions (page 18 of 24)